The quality of life after keratinized mucosa augmentation around dental implants using xenogenic collagen matrix with or without stent

Article type: Research Article

Authors: Wang, Tong-Yue^{a; 1} | Guo, Jin-Yuan^{b; 1} | Zhou, Zhen^a | Li, Shi-Yi^a | Li, Shao-Bing^a | Xu, Shu-Lan^{a; *}

Affiliations: [a] Center of Oral Implantology, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China | [b] Department Oral and Maxillofacial Surgery, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China

Correspondence: [*] Corresponding author: Shu-Lan Xu, Center of Oral Implantology, Stomatological Hospital, School of Stomatology, Southern Medical University, No. 366 South of Jiangnan Road, Guangzhou 510280, China. Tel.: +86 13922207002; +86 20 34304863; E-mail: shulanxuxx@126.com.

Note: [1] Tong-Yue Wang and Jin-Yuan Guo contributed equally to this work.

Abstract: BACKGROUND:The substitution of missing teeth with implants is a dependable and anticipated therapeutic approach. Despite numerous studies affirming long-term success rates, there exists a spectrum of potential biological and aesthetic complications. OBJECTIVE: The primary objective of this study was to assess patient responses subsequent to surgical interventions, with a specific emphasis on the utilization of xenogenic collagen matrix (XCM), both with and without the application of a stent secured over healing abutments, in the context of keratinized gingival mucosa augmentation. The principal aim was to evaluate and draw comparisons between the clinical outcomes resulting from these two procedural approaches, with a particular focus on critical parameters encompassing post-operative complications, patient comfort, and the overall efficacy in achieving successful keratinized tissue augmentation. METHODS: Sixty patients were selected for this study. The patients were divided into three groups: A, B, and a control group, with each group comprising 20 participants. We used XCM in experimental group A, XCM covered with surgical stent in experimental group B, and free gingival graft (FGG) in the control group. After the surgical procedure, patients were required to complete a visual analogue scale (VAS) questionnaire for post-operative complications, and a quality of life (QOL) questionnaire on days 1, 3, and 7. RESULTS: Patients in the experimental groups A and B demonstrated markedly improved outcomes when compared with the control group. Assessments conducted on days 1, 3, and 7 demonstrated diminished levels of pain, bleeding, and swelling in both experimental groups, with experimental group B showing the least discomfort. The incorporation of XCM, either with or without stents, was associated with a reduction in analgesic consumption, underscoring its favorable influence on post-operative comfort, notwithstanding the exception of halitosis in experimental group B. CONCLUSION: Using XCM with or without a stent for keratinized tissue augmentation has better post-operative outcomes associated with reduced swelling, bleeding, and pain based on the QOL survey. This study provides data to support the clinical application of XCM and stents.

Keywords: Collagen matrix, dental implants, keratinized mucosa, stents

DOI: 10.3233/THC-231863

Journal: Technology and Health Care, vol. 32, no. 5, pp. 3153-3166, 2024